EXAMS · SÃO PAULO
Ristocetin cofactor: test price, procedure, and preparation
A blood draw that checks whether a protein important for stopping bleeding is working as it should.

Understand the exam
When a blood vessel is injured, platelets need to stick to the injury site and clump together to stop the bleeding. Von Willebrand factor acts as a bridge between platelets and the vessel, and also protects factor VIII, another clotting protein.
Ristocetin is a substance used in the laboratory with the sample: it activates von Willebrand factor so that it binds to platelets. By measuring this binding, the test shows whether the factor is working, rather than just how much of it is in the blood. Measuring only the amount can miss some cases. That is why it is usually ordered along with tests that measure the amount of von Willebrand factor and factor VIII. Comparing the factor's activity with its amount helps distinguish type 1 from type 2 of the disease.
Von Willebrand factor levels can rise with inflammation, pregnancy, exercise, and birth control pills. People with type O blood tend to have naturally lower levels. Because levels vary over time, your doctor may ask you to repeat the test, depending on your situation.
How it is done
The test involves drawing blood from a vein in your arm using a thin needle. The blood goes into a tube designed for clotting tests (containing citrate), which must be filled to the correct level and taken to the laboratory within the required time.
The team provides any preparation instructions when you schedule. You will be told when to expect the results during your visit.
When it is recommended
- More bleeding than usual from the nose or mouth
- Very heavy periods
- Bruising easily
- Prolonged bleeding after dental treatment, surgery, or childbirth
- A family member diagnosed with von Willebrand disease
Does the exam hurt?
You may feel a small prick as the needle goes in or out. Mild pain may remain afterward and usually resolves quickly.
After the exam
Cost and health plans
| Exam | Self-pay | Duration | Health plans |
|---|---|---|---|
| Ristocetin cofactor | Starting at R$ 670.80 (≈ US$ 118, estimated) | Confirm with the team | Ask the team about coverage |
The team confirms the requested option, coverage, and conditions before booking.
Book an examFrequently asked questions
What is ristocetin?
It is a substance used in the laboratory and mixed with the sample to activate von Willebrand factor and see whether it can bind to platelets. It is not given to you: the sample is collected through a routine blood draw.
Do I need to fast for the ristocetin cofactor test?
The team provides preparation instructions when you schedule, along with instructions for any other tests on the same order.
Does a low result mean I have von Willebrand disease?
Not on its own. The diagnosis takes into account the person's and family's bleeding history, along with laboratory tests. A doctor interprets the results.
I am pregnant or use birth control. Does this affect the test?
Pregnancy and hormones containing estrogen can make von Willebrand factor appear falsely high on the test. Tell your doctor before the blood draw so they can decide when to perform the test.
Why did my doctor order other tests along with this one?
The ristocetin cofactor test shows how the factor functions, while other tests measure its amount and the activity of factor VIII. The ratio of the factor's activity to its amount helps distinguish type 1 from type 2 von Willebrand disease.
Why might I need to repeat the test?
Factor levels change with stress, exercise, hormones containing estrogen, and pregnancy. In many cases, the test needs to be repeated to reach a diagnosis.
Does my health plan cover the ristocetin cofactor test?
See the table on this page for plans with listed coverage. If your plan is not listed, the team confirms coverage for you.
Where we see patients
References
- Tosetto A, et al. Clinical and laboratory diagnosis of von Willebrand disease. Haematologica. 2026.
- Bowman M, et al. Diagnosis of von Willebrand disease. Blood Advances. 2025.
- Langer AL, O'Brien SH. The interplay of von Willebrand disease and women's reproductive health. Blood Advances. 2026.
- Baronciani L, et al. How we make an accurate diagnosis of von Willebrand disease. Thrombosis Research. 2020.
- Weyand AC, et al. Von Willebrand Disease: Current Status of Diagnosis and Management. Hematology/Oncology Clinics of North America. 2021.
- Smock KJ. Von Willebrand factor testing ratios in the diagnosis and subtyping of von Willebrand disease. International Journal of Laboratory Hematology. 2023.
- Colonne CK, et al. Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations. Journal of Blood Medicine. 2021.
- Keesler DA, et al. Current issues in diagnosis and treatment of von Willebrand disease. Research and Practice in Thrombosis and Haemostasis. 2018.
This content is informational and does not replace a consultation.
Updated on